Pages
Products
Panoply™ Human KARS Knockdown Stable Cell Line

Panoply™ Human KARS Knockdown Stable Cell Line

Cat.No. :  CSC-DC007893

Host Cell:  HEK293 (Hela and other cell types are also available) Validation:  Real-Time RCR

Inquire for Price

Cell Line Information

Safety and Packaging

Gene Informationn

Cat. No. CSC-DC007893
Description Creative Biogene's Knockdown Cell Lines are target specific shRNA lentivirus transduced cells. The percent knockdown levels range from 75-99% depending on the gene, as evaluated by Real-Time RCR. Cells are rigorously qualified and mycoplasma free.
Gene KARS
Host Cell HEK293 (Hela and other cell types are also available)
Host Cell Species Homo sapiens (Human)
Stability Validated for at least 10 passages
Application

(1) Studying gene functions

(2) Studying gene interactions and signaling pathways

(3) Target validation and drug discovery

(4) Designing diseases models

Quality Control Negative for bacteria, yeast, fungi and mycoplasma.
Size Form >1 × 10^6 cells / vial
Shipping Dry Ice
Storage Liquid Nitrogen
Gene Name
Gene Symbol
Gene Description
Gene ID
UniProt ID
mRNA Refseq
Protein Refseq
Chromosome Location
Function
Pathway
Mycoplasma Negative
Format One frozen vial containing millions of cells
Storage Liquid nitrogen
Safety Considerations

The following safety precautions should be observed.

1. Use pipette aids to prevent ingestion and keep aerosols down to a minimum.

2. No eating, drinking or smoking while handling the stable line.

3. Wash hands after handling the stable line and before leaving the lab.

4. Decontaminate work surface with disinfectant or 70% ethanol before and after working with stable cells.

5. All waste should be considered hazardous.

6. Dispose of all liquid waste after each experiment and treat with bleach.

Ship Dry ice
Quick Inquiry

Case Study

Publications

Q & A

Customer Reviews

HIV-1 reverse transcriptase (RT) is translated as part of the Gag-Pol polyprotein, which is subsequently proteolytically processed by HIV-1 protease (PR) to form a mature heterodimer composed of p66 and its derivative 51 kDa subunit, p51. Previous studies have shown that the binding of tRNALys3 to p66/p66 leads to a conformational change in the ribonuclease H (RNH) domain of RT, thereby promoting the efficient cleavage of p66 into p51 by PR. Here, researchers used nuclear magnetic resonance (NMR) spectroscopy to characterize the tRNALys3-induced conformational changes in the p66/p66 RNH domain. Furthermore, the importance of tRNALys3 in RT maturation was confirmed at the cellular level by modulating the levels of lysyl-tRNA synthetase, an enzyme that affects the binding of tRNALys3 to the virus. The researchers also used non-nucleoside RT inhibitors to modulate the p66 dimer-monomer equilibrium and monitored the resulting structural changes. Collectively, these data provide unique insights into how conformational changes in p66/p66 drive PR cleavage.

To investigate the role of tRNALys3 in the maturation process of reverse transcriptase (RT), researchers constructed KARS knockdown 293T cells and then transfected these cells with a full-length infectious HIV-1 molecular clone (HIV-1LAI) (Figure 1A). They observed intracellular RT accumulation, a phenomenon not seen in control cells (Figures 8B and 8C). Interestingly, p66 protein accumulated in KARS knockdown cells, but HIV-1 protease (PR) did not appear to efficiently process it into p51 (Figures 1B and 1C), suggesting that tRNALys3 may affect RT maturation in the cellular environment. Compared to control cells, KARS knockdown resulted in a significant reduction in viral particle production (as measured by p24 quantification) (Figure 1D). However, the p66:p51 ratio in the viral particles produced by KARS knockdown cells was 1:1 (Figures 1E and 1F), and there was no difference in the relative infectivity of the viruses produced by the control and KARS knockdown cell lines (measured in TZM-bL cells) (Figure 1G). These observations may indicate that tRNALys3 plays a role in viral assembly. Due to the low viral yield from these cells, the researchers were unable to measure tRNALys3 levels in the viral particles produced by the KARS knockdown cell line.

Figure 1. siRNA-Mediated Knockdown of KARS in 293T Cells.Figure 1. siRNA-Mediated Knockdown of KARS in 293T Cells. (Slack R L, et al., 2019)

Ask a Question

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

Write a Review

Write a review of your use of Biogene products and services in your research. Your review can help your fellow researchers make informed purchasing decisions.

Needs improvement

Satisfaction

General satisfaction

Very satisfaction